Snijders, Malou L. H., Varol, Hilal, van der Zwan, Marieke, Becker, Jan U., Hesselink, Dennis A., Baan, Carla C., von der Thusen, Jan H. and Clahsen-van Groningen, Marian C. (2020). Molecular Analysis of Renal Allograft Biopsies: Where Do We Stand and Where Are We Going? Transplantation, 104 (12). S. 2478 - 2487. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1534-6080

Full text not available from this repository.

Abstract

A renal core biopsy for histological evaluation is the gold standard for diagnosing renal transplant pathology. However, renal biopsy interpretation is subjective and can render insufficient precision, making it difficult to apply a targeted therapeutic regimen for the individual patient. This warrants a need for additional methods assessing disease state in the renal transplant. Significant research activity has been focused on the role of molecular analysis in the diagnosis of renal allograft rejection. The identification of specific molecular expression patterns in allograft biopsies related to different types of allograft injury could provide valuable information about the processes underlying renal transplant dysfunction and can be used for the development of molecular classifier scores, which could improve our diagnostic and prognostic ability and could guide treatment. Molecular profiling has the potential to be more precise and objective than histological evaluation and may identify injury even before it becomes visible on histology, making it possible to start treatment at the earliest time possible. Combining conventional diagnostics (histology, serology, and clinical data) and molecular evaluation will most likely offer the best diagnostic approach. We believe that the use of state-of-the-art molecular analysis will have a significant impact in diagnostics after renal transplantation. In this review, we elaborate on the molecular phenotype of both acute and chronic T cell-mediated rejection and antibody-mediated rejection and discuss the additive value of molecular profiling in the setting of diagnosing renal allograft rejection and how this will improve transplant patient care.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Snijders, Malou L. H.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Varol, HilalUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
van der Zwan, MariekeUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Becker, Jan U.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Hesselink, Dennis A.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Baan, Carla C.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
von der Thusen, Jan H.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Clahsen-van Groningen, Marian C.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-310428
DOI: 10.1097/TP.0000000000003220
Journal or Publication Title: Transplantation
Volume: 104
Number: 12
Page Range: S. 2478 - 2487
Date: 2020
Publisher: LIPPINCOTT WILLIAMS & WILKINS
Place of Publication: PHILADELPHIA
ISSN: 1534-6080
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
ANTIBODY-MEDIATED REJECTION; KIDNEY-TRANSPLANT BIOPSIES; DONOR-SPECIFIC ANTIBODIES; NK CELL TRANSCRIPTS; NON-HLA ANTIBODIES; GENE-EXPRESSION; INTERNATIONAL VARIATION; MICROARRAY DIAGNOSIS; ENDOTHELIAL INJURY; PROGNOSTIC SCOREMultiple languages
Immunology; Surgery; TransplantationMultiple languages
URI: http://kups.ub.uni-koeln.de/id/eprint/31042

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item